Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001750284-18-000001
Filing Date
2018-08-27
Accepted
2018-08-27 13:01:57
Documents
1
Effectiveness Date
2018-08-27
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11254
  Complete submission text file 0001750284-18-000001.txt   12291
Mailing Address 665 3RD STREET SUITE 250 SAN FRANCISCO CA 94107
Business Address 665 3RD STREET SUITE 250 SAN FRANCISCO CA 94107 4157428265
Olema Pharmaceuticals, Inc. (Filer) CIK: 0001750284 (see all company filings)

EIN.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-320082 | Film No.: 181038566